Resources

Researchers predict that by 2025, approximately one in three adults over age 20 – or 1.56 billion people worldwide – will have high blood pressure.

For the first time it has been shown that both raising HDL stops plaques in the arteries from getting larger and also prevents heart events. Until this study no previous study has focused on both.

Chlorthalidone-based treatment improves long-term outcomes associated with isolated systolic hypertension, especially among patients with diabetes.

Finding offers new target for controlling obesity and diabetes. Lipin controls what burns first, fats or carbs.

The capacity for endurance exercise is linked to cardiovascular health which is good news for long- distance runners.

Use of ezetimibe with simvastatin, is well tolerated and provides greater LDL-C-lowering efficacy than increasing the dose of simvastatin in T2DM patients taking TZDs.

Patients with type 2 diabetes, subclinical left ventricular dysfunction is common and associated with poor diabetic control.

Heart patients with gastrointestinal complications should use low doses of aspirin combined with drugs that treat stomach ulcers rather than taking the anti-platelet drug Plavix, thought to reduce bleeding ulcers.

Men with type 2 diabetes seem to be less likely to develop prostate cancer, overall.

Intensive glycemic control is highly effective for treating sepsis, but it may be harmful for brain injury patients.